Nov 2026· Frontiers in Immunology· Vol 17· 0 citations· 167 references
TL;DR
It is believed that in-depth exploration of the immunoregulatory mechanisms of CD8 + T cells in AD can provide theoretical foundations and new perspectives for developing innovative immunotherapies targeting neuroinflammation and cognitive impairment in AD.
Abstract
Alzheimer’s disease (AD) is the most common neurodegenerative disease in the world, and its pathogenesis is very complex, posing a serious threat to human health. The reciprocal regulation of the nervous and immune systems plays a key role in driving AD progression, although the specific mechanisms remain to be elucidated. In recent years, attention has increasingly focused on the role of adaptive immune cells in AD. Among them, CD8
+
T cells have been found to infiltrate the brain parenchyma of AD patients, and this phenomenon is closely associated with neuronal injury and cognitive decline. This review first outlines the epidemiology and pathomechanisms of AD and systematically summarizes CD8
+
T cell activation, cytotoxicity, migration, and function. It emphasizes the dual potential role of these cells in AD. These cells may exacerbate neuronal injury and cognitive dysfunction through multiple pathways, including direct cytotoxicity, release of pro-inflammatory cytokines, disruption of the blood–brain barrier, and inhibition of neuroplasticity. However, under specific microenvironmental conditions, CD8
+
T cells may also exert immunomodulatory functions and confer potential protective effects. This review also discusses related therapeutic strategies based on these mechanisms. Finally, we discuss the difficulties currently facing research and future directions for clinical translation. We believe that in-depth exploration of the immunoregulatory mechanisms of CD8
+
T cells in AD can provide theoretical foundations and new perspectives for developing innovative immunotherapies targeting neuroinflammation and cognitive impairment in AD.
Alzheimer's disease (AD) is now recognized as a biologically heterogeneous syndrome in which amyloid-β pathology, Tau-related alterations, and neuroinflammation are key interconnected processes. Microglia, astrocytes, oligodendrocytes, complement, inflammasomes, neurovascular cells, and peripheral immunity are implicat...
Priyanka Samantaray, Poonam Verma· Molecular and cellular neuro...· 1 citation
Alzheimer’s disease-related dementias (ADRD) are progressive neurodegenerative disorders and the most common cause of dementia worldwide. Despite extensive research into their underlying molecular and cellular mechanisms, therapeutic options remain limited. Current pharmacological treatments offer only modest symptomat...
Srivani Gowru, Opeyemi B. Fasina, Usman Sunusi et al.· Frontiers in Aging Neuroscie...· 0 citations
The gradual degeneration of brain cells, known as synapses and neurones, is the main cause of memory loss and cognitive dysfunction in Alzheimer's disease (AD), a neurodegenerative disorder. Chronic neuroinflammation is an important factor in the development and advancement of the illness, with characteristic pathologi...
Vaishnavi Vijay, Patil, V. Patil et al.· International Journal of Dru...· 0 citations
Alzheimer’s disease (AD) has traditionally been interpreted through amyloid, tau, and innate immune frameworks, with the complement cascade long regarded as the principal driver of aberrant synaptic pruning. Synaptic loss is increasingly recognized as one of the strongest correlates of cognitive decline. This review ex...
The central nervous system (CNS), previously considered immune-isolated due to the blood-brain barrier (BBB) and absence of lymphatic drainage, is now understood as a dynamic interface with the peripheral immune system. CNS neurons and glia actively modulate immune responses, and circulating T cells survey and sometime...
Hamed Afkhami, Mohammad Hasan Yousefi, Tahereh Zarei Taher et al.· Experimental Cell Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.